A member asked:

Nsclc kras wild adeno iv. seems taxol (paclitaxel) + carboplatin (+erbitux) weekly instead of 3 weekly has min side efex. so why recommend every three weeks?

2 doctors weighed in across 2 answers

Clinical trials : Most physicians use 3 week Carboplatin and paclitaxol therapy for adenocarcinoma nsclc. This is mostly due to clinical trial data supporting the every 3 week regimens. Neuropathy is typically greater with weekly treatments. I usually will use Erbitux in combination with Cisplatin Navelbine (vinorelbine) based on clinical studies. Ask your physician because chemo choices are sometimes related to comorbid disease.

Answered 6/30/2014

5.5k views

Thank

Alternative: Differen protocol. Talk to your oncologist, he is the only one that can advise.

Answered 3/27/2013

5.2k views

Thank

Related Questions

A member asked:

What side effects are associated with Taxol (paclitaxel)?

A doctor has provided 1 answer